- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Govt approves investment by FIL Capital in Cipla Health
New Delhi : Drug major Cipla said the government has approved an investment by Mauritius-based FIL Capital Investments in its subsidiary, Cipla Health Ltd.
"...It appears that the government has, based on the recommendations of the Foreign Investment Promotion Board, approved the proposed investment by FIL Capital Investments (Mauritius) II Ltd in Cipla Health Ltd, subsidiary of the company," Cipla said in a BSE filing.
The investment is still subject to other conditions precedent and the transfer of company's consumer healthcare business to Cipla Health Ltd, it added.
The government yesterday approved 10 foreign investment proposals involving an inflow of Rs 607 crore, including Cipla's proposal of Rs 145.22 crore.
In November last year, Cipla said in a regulatory filing that Cipla Health Ltd and FIL Capital Investments (Mauritius) II Ltd have signed an investment agreement for its consumer healthcare business.
"...It appears that the government has, based on the recommendations of the Foreign Investment Promotion Board, approved the proposed investment by FIL Capital Investments (Mauritius) II Ltd in Cipla Health Ltd, subsidiary of the company," Cipla said in a BSE filing.
The investment is still subject to other conditions precedent and the transfer of company's consumer healthcare business to Cipla Health Ltd, it added.
The government yesterday approved 10 foreign investment proposals involving an inflow of Rs 607 crore, including Cipla's proposal of Rs 145.22 crore.
In November last year, Cipla said in a regulatory filing that Cipla Health Ltd and FIL Capital Investments (Mauritius) II Ltd have signed an investment agreement for its consumer healthcare business.
Next Story